Announced Thu, 7 May · 19:49 IST

Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates

Corporate Actions View source PDF

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.1%1-day move
₹1208.00
prior close
₹1269.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.4-2.7-2.5-2.9+10.1+6.0+7.0+6.0+11.3+8.0+3.4+8.1+10.1
Up moveDown movePending
AI summary

Vijaya Diagnostic Centre Limited held its Board meeting on May 07, 2026, approving several key items. The Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1) for FY 2026, subject to shareholder approval at the AGM. An Independent Director, Dr. D Nageshwar Reddy, will not seek re-appointment for a second term due to pre-occupation and other commitments. The company granted 1,79,500 ESOPs to employees at ₹784 per option (20% discount on 3-month average price) under VDCL Employee Stock Option Plan 2018. Additionally, the company approved acquisition of MRI, EEG and NCV services business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, with operations in Kolkata generating annual turnover of around ₹2.3-2.5 crore.

Likely market impact

The dividend recommendation and ESOP grants are positive signals for shareholder returns and employee retention. The acquisition of the diagnostic services business from the subsidiary is a strategic consolidation move that could streamline operations and create growth opportunities. The departure of Dr. Nageshwar Reddy represents a minor governance change with no material concerns noted.